Comparison Chart Damora Therapeutics, Inc.
Stocks
DMRA
KYG2646Y1044
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
22:00:35 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 22.70 USD | -0.37% |
|
-19.32% | -1.48% |
| 08-11 | Damora Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-05 | Damora Therapeutics Begins Trial of DMR-001 in ET, Myelofibrosis | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DAMORA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -0.13% | -19.32% | -1.48% | +689.90% | -76.81% | 1.41B |  |  |  |
- Stock Market
- Stocks
- DMRA Stock
- Charts Damora Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
